Subscribe To
Allient inc. (alnt) q3 2023 earnings call transcript
Allient Inc. (NASDAQ:ALNT ) Q3 2023 Earnings Conference Call November 2, 2023 10:00 AM ET Company Participants Craig Mychajluk - Investor Relations Ri...
November 4, 2023, 11:37 am
Hugo boss ag (bossy) q3 2023 earnings call transcript
HUGO BOSS AG (OTCPK:BOSSY) Q3 2023 Earnings Conference Call November 2, 2023 6:00 AM ET Company Participants Yves Müller - CFO & COO Christian Stohr ...
November 4, 2023, 8:52 am
Endesa, s.a. (elezf) q3 2023 earnings call transcript
Endesa, S.A. (OTCPK:ELEZF) Q3 2023 Earnings Conference Call October 31, 2023 5:00 AM ET Company Participants Mar Martinez - Investor Relations Jose Bo...
November 4, 2023, 7:33 am
Replimune presents updated interim results from the artacus clinical trial of rp1 monotherapy in solid organ and hematopoietic cell transplant recipients with skin cancers during oral presentation at
RP1 as monotherapy showed clear anti-tumor activity with an overall response rate of nearly 35 percent in evaluable patients WOBURN, Mass., Nov. 03, 2...
November 3, 2023, 11:30 pm
Replimune presents updated interim results from the artacus clinical trial of rp1 monotherapy in solid organ and hematopoietic cell transplant recipients with skin cancers during oral presentation at
RP1 as monotherapy showed clear anti-tumor activity with an overall response rate of nearly 35 percent in evaluable patients WOBURN, Mass., Nov. 03, 2...
November 3, 2023, 11:30 pm
Replimune presents updated interim results from the artacus clinical trial of rp1 monotherapy in solid organ and hematopoietic cell transplant recipients with skin cancers during oral presentation at
RP1 as monotherapy showed clear anti-tumor activity with an overall response rate of nearly 35 percent in evaluable patients WOBURN, Mass., Nov. 03, 2...
November 3, 2023, 11:30 pm
Replimune presents updated interim results from the artacus clinical trial of rp1 monotherapy in solid organ and hematopoietic cell transplant recipients with skin cancers during oral presentation at
RP1 as monotherapy showed clear anti-tumor activity with an overall response rate of nearly 35 percent in evaluable patients WOBURN, Mass., Nov. 03, 2...
November 3, 2023, 11:30 pm
New preliminary clinical data on potential of opus aav-based gene therapy for rare inherited retinal disease to be presented at the american academy of ophthalmology annual conference 2023
Data to be presented as part of gene augmentation therapy presentation RALEIGH, N.C., Nov. 03, 2023 (GL...
November 3, 2023, 7:43 pm
Actinium pharmaceuticals: the trickle down continues, and i maintain a buy
Actinium Pharmaceuticals continues to make progress with their radiolabelled CD45 antibody Iomab-B, which has potential beyond market expectations. Th...
November 3, 2023, 6:08 pm
Murphy usa inc. announces participation in upcoming conference
EL DORADO, Ark.--(BUSINESS WIRE)--Murphy USA Inc. (NYSE: MUSA) today announced participation in an upcoming investor conference. Andrew Clyde, Preside...
November 3, 2023, 4:31 pm
Mettler-toledo international inc. to present at upcoming investor conferences
COLUMBUS, Ohio--(BUSINESS WIRE)--Mettler-Toledo International Inc. (NYSE: MTD) today announced it will present at the Stifel Healthcare Conference on ...
November 3, 2023, 4:30 pm
Intesa sanpaolo s.p.a. (isnpy) q3 2023 earnings call transcript
Intesa Sanpaolo S.p.A. (OTCPK:ISNPY) Q3 2023 Results Conference Call November 3, 2023 10:00 AM ET Company Participants Carlo Messina - Chief Executive...
November 3, 2023, 2:50 pm
Aker asa (akaaf) q3 2023 earnings call transcript
Aker ASA (OTCPK:AKAAF) Q3 2023 Results Conference Call November 3, 2023 4:00 AM ET Company Participants Fredrik Berge - Head of Investor Relations Oyv...
November 3, 2023, 2:19 pm
Ai and big data virtual investor conference: presentations now available for online viewing
Company Executives Share Vision and Answer Questions Live at VirtualInvestorConferences.com NEW YORK, Nov. 03, 2023 (GLOBE NEWSWIRE) — Virtual Inves...
November 3, 2023, 12:35 pm
Fulgent genetics, inc. (flgt) q3 2023 earnings call transcript
Fulgent Genetics, Inc. (NASDAQ:FLGT ) Q3 2023 Earnings Call Transcript November 3, 2023 8:30 AM ET Company Participants Melanie Solomon - IR Ming Hsie...
November 3, 2023, 12:22 pm
Galectin therapeutics to share five scientific presentations at the liver meeting™ 2023, hosted by the aasld
Pharmacokinetics and safety of belapectin in patients with hepatic insufficiency Lack of impact of belapectin on cardiac repolarization (QT interval) ...
November 3, 2023, 12:00 pm
Starbucks taps additional rewards partnerships to widen loyalty audience
Starbucks is adding two new rewards partners to grow loyalty engagement and reach new customers. The world's largest restaurant chain by revenue share...
November 3, 2023, 11:28 am
Acerinox, s.a. (anioy) q3 2023 earnings call transcript
Acerinox, S.A. (OTCPK:ANIOY) Q3 2023 Earnings Conference Call November 3, 2023 8:00 AM ET Company Participants Carlos Lora-Tamayo - Chief Investor Rel...
November 3, 2023, 11:22 am
Gilead to present late breaking data and real world evidence highlighting key hepatitis indications at the liver meeting® 2023
FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) today announced the presentation...
November 3, 2023, 11:00 am
Turnstone biologics presents preclinical data highlighting potential for selected tumor-infiltrating lymphocyte (til) therapy in solid tumors at the 2023 society for immunotherapy of cancer (sitc) ann
presentations showcase Turnstone’s novel Selected TIL programs which are designed to selectively expa...
November 3, 2023, 10:00 am